| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3344642 | The Brazilian Journal of Infectious Diseases | 2010 | 6 Pages |
Abstract
This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the first integrase inhibitor licensed to treat HIV-1 infection.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
